Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Oct 5:14:1242014.
doi: 10.3389/fphar.2023.1242014. eCollection 2023.

Editorial: Innovation in ocular pharmacology

Lucia Gozzo  1 , Mario Damiano Toro  2 , Vittorio Porciatti  3 , Giovanni Luca Romano  4
Affiliations
Editorial

Editorial: Innovation in ocular pharmacology

Lucia Gozzo et al. Front Pharmacol. .
No abstract available

Keywords: innovative treatment; ocular disease; ocular pharmacology; pharmacological targets; unmet medical need.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Comment on

  • Editorial on the Research Topic Innovation in ocular pharmacology

References

    1. Alajbegovic-Halimic J., Zvizdic D., Alimanovic-Halilovic E., Dodik I., Duvnjak S. (2015). Risk factors for retinopathy of prematurity in premature born children. Med. Arch. 69 (6), 409–413. 10.5455/medarh.2015.69.409-413 - DOI - PMC - PubMed
    1. Bucolo C., Drago F. (2004). Effects of neurosteroids on ischemia-reperfusion injury in the rat retina: Role of sigma1 recognition sites. Eur. J. Pharmacol. 498 (1-3), 111–114. 10.1016/j.ejphar.2004.06.067 - DOI - PubMed
    1. Conti F., Romano G. L., Eandi C. M., Toro M. D., Rejdak R., Di Benedetto G., et al. (2021). Brimonidine is neuroprotective in animal paradigm of retinal ganglion cell damage. Front. Pharmacol. 12, 705405. 10.3389/fphar.2021.705405 - DOI - PMC - PubMed
    1. Cursiefen C., Cordeiro F., Cunha-Vaz J., Wheeler-Schilling T., Scholl H. P. N. EVI Steering Board (2019). Unmet needs in ophthalmology: A European vision institute-consensus roadmap 2019-2025. Ophthalmic Res. 62 (3), 123–133. 10.1159/000501374 - DOI - PubMed
    1. Falavarjani K. G., Nguyen Q. D. (2013). Adverse events and complications associated with intravitreal injection of anti-VEGF agents: A review of literature. Eye (Lond) 27 (7), 787–794. 10.1038/eye.2013.107 - DOI - PMC - PubMed

Publication types